1 / 1

Best Regorafenib Stivarga Blog You Should Read

Regorafenib, also available under the brand name Stivarga among few others, is classified as an Oral Multi-Kinase Inhibitor that is developed by Bayer which targets Angiogenic, Stromal and Oncogenic Receptor Tyrosine Kinase. Regorafenib projects Anti-Angiogenic actions due to its dual targeted VEGFR2-TIE2 Tyrosine Kinase inhibition. For more information visit https://www.genuinedrugs123.com/Blog-180-Best-regorafenib-stivarga-blogs-you-should-read.aspx

Download Presentation

Best Regorafenib Stivarga Blog You Should Read

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


    More Related